Motexafin Gadolinium
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Motexafin Gadolinium, covering 2007-03-05 to 2021-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma [Phase 2]